Abstract Interspecies interactions are the basis of microbial community formation and infectious diseases. Systems biology enables the construction of complex models describing such interactions, leading to a better understanding of disease states and communities. However, before interactions between complex organisms can be understood, metabolic and energetic implications of simpler real-world host-microbe systems must be worked out. To this effect, untargeted metabolomics experiments were conducted and integrated with proteomics data to characterize key molecular-level interactions between two hyperthermophilic microbial species, both of which have reduced genomes. Metabolic changes and transfer of metabolites between the archaea Ignicoccus hospitalis and Nanoarcheum equitans were investigated using integrated LC-MS and NMR metabolomics. The study of such a system is challenging, as no genetic tools are available, growth in the laboratory is challenging, and mechanisms by which they interact are unknown. Together with information about relative enzyme levels obtained from shotgun proteomics, the metabolomics data provided useful insights into metabolic pathways and cellular networks of I. hospitalis that are impacted by the presence of N. equitans, including arginine, isoleucine, and CTP biosynthesis. On the organismal level, the data indicate that N. equitans exploits metabolites generated by I. hospitalis to satisfy its own metabolic needs. This finding is based on N. equitans's consumption of a significant fraction of the metabolite pool in I. hospitalis that cannot solely be attributed to increased biomass production for N. equitans. Combining LC-MS and NMR metabolomics datasets improved coverage of the metabolome and enhanced the identification and quantitation of cellular metabolites.
Introduction
In the environment, microbes do not live in isolation, but rather constantly respond to the presence of other species, adapting their metabolic needs and resources to optimize growth and survival among species that share similar ecological niches. Microbial communities depend on specific and complex mechanisms of interspecies interactions Timothy Hamerly, Brian P. Tripet and Michelle Tigges have contributed equally to this work. and communications, forming sophisticated interspecies networks ranging from mutualism to symbiosis or parasitism. Such interspecies relationships impact the role of keystone species in an ecological community, play a major role in energy and elemental cycles, and form the foundation of host-pathogen interactions.
Despite a long history of research focused on understanding the molecular mechanisms underlying hostmicrobe interactions, and the growing interest in identifying microbial metacommunities, fundamental processes of interspecies recognition, interactions, and communication remain unclear. In particular, little is known about the biochemical processes by which mutualism and syntrophy (i.e. metabolic interdependence) impact microbial genome evolution, and how metabolism and energetic coupling between species affect host-microbe homeostasis and their responses to environmental factors. Such a lack of fundamental knowledge is most prevalent for organisms from the Archaeal domain of life, such as Ignicoccus hospitalis and Nanoarchaeum equitans, which engage in one of the simplest symbiotic/parasitic systems known Junglas et al. 2008; Podar et al. 2008) .
The reduced genome complexity of I. hospitalis and N. equitans is an attractive model for the study of fundamental cellular, genomic, and metabolic principles guiding inter-species interactions, as the genomes of both organisms have been sequenced, a metabolic map of the Ignicoccus-Nanoarcheum system has been reconstructed, and some of the biochemical pathways and cellular complexes have been experimentally validated (Huber et al. , 2003 Jahn et al. 2007 Jahn et al. , 2004 ; Küper et al. 2010; Podar et al. 2008; Waters et al. 2003) .
Ignicoccus is a genus of marine hyperthermophilic, chemolithoautotrophic Archaea, classified to the order Desulfurococcales (Huber et al. 2000) . These organisms reduce elemental sulfur with hydrogen as a source of energy and use carbon dioxide as the sole carbon source . Ignicoccus species possesses some of the smallest genomes of a free living organism, some having less than 1,500 genes (Podar et al. 2008) . One species of this genus (I. hospitalis) has been shown to act as a host for one of the smallest organisms known, Nanoarchaeum equitans, which encodes approximately 550 proteins. It lacks many of the genes required for energy production and depends exclusively on Ignicoccus for survival (Giannone et al. 2011; Huber et al. 2002 Huber et al. , 2003 Paper et al. 2007) . N. equitans is a member of the proposed phylum Nanoarchaeota, and currently the only cultivated organism from that group of Archaea (Huber et al. 2000 (Huber et al. , 2002 .
Investigations of the protein composition of N. equitans reveal that it is comprised of a very minimal proteome with important bioenergetic proteins and protein complexes missing or incomplete (Giannone et al. 2011 (Giannone et al. , 2014 Waters et al. 2003 ). In addition, N. equitans is unable to synthesize many metabolites and lipids on its own, and relies on essential cellular nutrients and metabolic components that are provided via interactions and cell-cell contacts with I. hospitalis (Burghardt et al. 2009; Huber et al. 2012; Jahn et al. 2004) . Despite these observations, it remains to be established whether N. equitans is a parasite or provides an advantage to I. hospitalis, as the latter does not seem to benefit or suffer when grown in co-culture with N. equitans (Burghardt et al. 2009; Giannone et al. 2011; Godde 2012; Huber et al. 2012; Jahn et al. 2008 Jahn et al. , 2004 Junglas et al. 2008) .
In order to better understand the foundational biochemistry and metabolic networks regulating I. hospitalis-N. equitans interspecies interactions, we have undertaken an untargeted mass spectrometry (MS) and nuclear magnetic resonance (NMR)-based metabolomics study of this archaeal host-microbe model system. Utilization of both NMR and MS have enabled us to take advantage of the complementarity of the two techniques for metabolomics analysis, and to establish distinct metabolite profiles of I. hospitalis alone and when grown in co-culture with N. equitans. The metabolomics data thus acquired have been integrated with published genomics and proteomics information using Pathway Tools, to generate a multilevel model of cellular processes (genes, proteins, metabolites) and metabolic networks that regulate I. hospitalis and N. equitans interactions (Giannone et al. 2014; Karp and Paley 1996; Karp et al. 2005 Karp et al. , 2010 Karp et al. , 2002 Paley et al. 2012) . Results from the global analysis of these multi ''omics'' data suggest that N. equitans exploits metabolites produced by I. hospitalis to satisfy its own metabolic needs, while still allowing both organisms to live.
Materials and methods

Materials
All solvents from metabolite extraction and LC-MS analysis were purchased in HPLC grade; water from Avantor (Center Valley, PA) and methanol and acetonitrile from EMD Chemicals Inc. (Gibbstown, NJ). Formic acid (98 % GR ACS) for use as an ion pairing agent was purchased from EMD Chemicals Inc. (Gibbstown, NJ). DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) used for NMR spectral reference and metabolite quantification was purchased from Sigma. All solvents were used as supplied without further purification.
Cell culturing
I. hospitalis and I. hospitalis-N. equitans were cultured for 24 h in 1 liter bottles containing 250 ml 0.5X SME medium, sulfur (10 g/l) and a H 2 -CO 2 (80-20 %) gas phase (15 psi), at 85°C, as described previously . Prior to harvesting, the cultures were cooled to room temperature, chilled on ice and the cells were collected by centrifugation (8,0009g for 20 min). The cell pellets were washed with cold anaerobic 0.5X SME medium, aliquoted in small tubes, and flash frozen with liquid nitrogen under N 2 gas, and stored at -80°C.
Metabolite extraction
Intracellular metabolites from I. hospitalis and I. hospitalis-N. equitans co-cultures for LC-MS and NMR analysis were extracted using a 50 % aqueous (v/v) MeOH extraction, modified from a previously published protocol (Heinemann et al. 2014) . Briefly, frozen cell pellets weighing 50 mg for LC-MS analysis and 115 mg for NMR analysis, were re-suspended in 300 lL of 50 % MeOH (v/v), vortexed for 30 s, and lysed by sonication for 5 min on ice. The resulting samples were then incubated for 1 h at -20°C to allow diffusion of metabolites into the bulk liquid. Following this step, cell debris was pelleted by centrifugation for 15 min at 20,0009g and supernatant was collected. Cell debris was then washed with an additional volume of 50 % MeOH (v/v), vortexed for 30 s, centrifuged, and supernatant pooled. Proteins were precipitated using 5:1 dilution with cold acetone, left overnight at -80°C, and centrifuged. The resulting supernatant was collected and dried via vacuum speed concentration, and stored at -80°C. For LC-MS analysis, metabolite extracts were re-suspended in 50 % MeOH.
LC-MS based metabolomic analysis
For reverse phase analysis, a Kinetex 1.7 lm C18 150 9 2.1 mm column (Phenomenex, Torrance, CA) kept at 50°C was used for LC separation with a flow rate of 600 lL min -1 . Solvent A consisted of 0.1 % formic acid in water, while solvent B was 0.1 % formic acid in acetonitrile. The elution gradient consisted of 2 % solvent B for 2 min (with the first two minutes going to waste to avoid contaminating the source with excess salt), to 95 % solvent B over 24 min, held at 95 % for 2 min, and then returned to 2 % for 2 min, with a total run time of 30 min using an Agilent 1290 UPLC (Agilent, Santa Clara, CA) system connected to an Agilent 6538 Q-TOF Mass Spectrometer (Agilent, Santa Clara, CA).
Normal phase analysis used a Cogent Diamond Hydride HILIC 150 9 2.1 mm column (MicroSolv, Eatontown, NJ) was used for LC separation with a flow rate of 600 lL min -1 . Solvent A consisted of 0.1 % formic acid in water, while solvent B consisted of 0.1 % formic acid in acetonitrile. The elution gradient consisted of 95 % solvent B for 2 min (with the first minute going to waste to avoid contaminating the source with excess salt), to 50 % solvent B over 24 min, held at 50 % for 2 min, and then returned to 95 % for 2 min, with a total run time of 30 min using an Agilent 1290 UPLC (Agilent, Santa Clara, CA) system connected to an Agilent 6538 Q-TOF Mass Spectrometer (Agilent, Santa Clara, CA).
Mass spectrometry analysis was conducted in positive ion mode, with a cone voltage of 3,500 V and a fragmentor voltage of 120 V. Drying gas temperature was 350°C with a flow of 12 L min -1 and the nebulizer was set to 60 psig. Spectra were collected at a rate of 2.52 per second with a mass range of 50-1,000 m/z. The mass analyzer resolution was 18,000 and post calibration tests had a mass accuracy of approximately 1 ppm.
Identification of compounds with retention time matches to standards was strengthened with fragmentation analysis (MS/MS) when possible. LC and MS parameters were the same as listed above. For MS/MS acquisition, both standard compounds and ions of interest from the samples were selected in a window of ±1.7 m/z units, and fragmented at 10 and 20 V.
LC-MS data processing and analysis
Data files from the LC-MS were converted to MZxml format using the Masshunter Qualitative software provided with Agilent instruments (Agilent, Santa Clara, CA). Analysis of LC-MS data was done using the software package MZmine (version 2.10). Procedures, together with parameters used for the alignment of features and identification in MZmine, were as follows: LC-MS files were imported into MZmine, followed by data set filtering to remove the first minute of elution data for HILIC analysis, and the first two minutes of elution data for RP analysis. A minimum intensity cutoff of 5,000 and a minimum elution time window of 0.1 min were used to create molecular feature lists. Lists included retention time (R/T) adjustment with a tolerance of 0.2 min or less. These R/T-adjusted lists were then aligned into one mass list, and then gap-filled to add missing peaks not detected in all runs with an m/z tolerance of 15.0 ppm. Identification of compounds was based on annotated pathways in Biocyc, or standard compounds based on R/T and m/z was done on these finalized lists with an m/z tolerance of 30 ppm and for the standards a retention time tolerance of 0.25 min (Karp et al. 2005 (Karp et al. , 2002 . Metabolite identities were each manual annotated to ensure strong matches, tandem mass spectrometry was done to further confirm metabolite ID. Lists of aligned and R/T adjusted molecular features were analyzed using principal component analysis (PCA) using the XLSTAT software package (Addinsoft 2013). Ions selected for MS/ MS identification were confirmed by matching fragmented peaks and intensities to those of the standard compounds. 1 H spectral window of 9,600 Hz. FIDS were collected in 32 K time data points, with a dwell time interval of 52 ls between points amounting to an acquisition time of *1.7 s, using a 2 s relaxation recovery time delay between FID acquisitions, and a NOESY mixing time period of 50 ms. Pulse sequence settings were based on standard recommendations by the Chenomx TM user guide for recording 1D 1 H NMR spectra of small molecules and for quantitation of metabolites.
Spectral processing and analysis was performed using the Chenomx TM software (version 7.6) (Chenomx Inc., Edmonton, AB, Canada). For each sample, NMR spectra were phased, baseline corrected, and a line broadening function of 0.5 Hz was applied, following recommended Chenomx protocols and previously reported metabolomics analysis methods (Sun et al. 2012; Tredwell et al. 2011; Weljie et al. 2006; Wu et al. 2010) . For metabolite identification, the Chenomx small molecule library for 600-MHz ( 1 H Larmor frequency) magnetic field strength NMR spectrometers was used, and NMR spectral patterns were fitted for each sample independently. Metabolite identifications were further confirmed by analysis of 2D 1 H-1 H total correlation spectroscopy (TOCSY) spectra or by spiking, when available, pure metabolite standards into the samples. An internal DSS standard was used for quantitation of identified metabolites. Equivalent weight cell pellets were used to prepare the NMR samples and post data acquisition and metabolite profiling analysis, NMR spectra were normalized based on protein concentration in the insoluble and soluble pellet fractions as determined by SDS-PAGE analysis. This added normalization step corrected for a significant presence of inorganic sulfur present in the pellet of the I. hospitalis-N. equitans co-culture, and the inability to obtain direct cell counts from cell pellets provided for metabolomics analysis.
Pathway tools analysis of overlayed metabolomic and proteomic datasets
Using the Pathway Tools v17.5 software (SRI International), NMR and LC-MS metabolite identities and abundances were overlaid with previously published proteomics datasets for I. hospitalis only cultures and I. hospitalis-N. equitans co-cultures (Giannone et al. 2011 (Giannone et al. , 2014 Karp and Paley 1996; Karp et al. 2005 Karp et al. , 2010 Karp et al. , 2002 Paley et al. 2012) . Metabolite identities and their associated fold changes were overlaid onto the IHOS453591 Cyc version 17.0 database, which is available directly from the Biocyc webservers (Karp et al. 2005 (Karp et al. , 2002 . The constructed pathway tools database was further curated and adjusted based on analysis of the published literature on I. hospitalis and N. equitans.
Firefly luciferase assay for quantitation of ATP
Determination of ATP concentrations in both cultures was carried out using the BacTiter-Glo Firefly Luciferase Assay (Promega, Madison, WI) following the protocol included with the kit (Promega Corporation 2012). Briefly, BacTiter-Glo buffer and BacTiter-Glo substrate were equilibrated to room temperature. Substrate was then re-suspended in 10 mL buffer with gentle vortexing to form the BacTiterGlo reagent. To perform the ATP measurements, 6.5 mg of I. hospitalis and I. hospitalis-N. equitans co-culture cell pellets were re-suspended in 100 lL of H 2 O, and placed into a white 96-well plate. Cells in solution were allowed to equilibrate to room temperature, and then an equal volume (100 lL) of BacTiter-Glo reagent was added to each well with cells, as well as to a well containing 100 lL of H 2 O only to serve as a blank. A standard curve of ATP concentrations was generated from 1 lM to 10 pM from a 1 lM stock solution and mixed with BacTiter-Glo reagent and also placed in the same white 96-well plate. The plate was placed on an orbital shaker (Thermoscientific) for 5 min to assist with cell lysis. Luminescence readings for the assay were recorded on a Fluoroskan Ascent FL Microplate Luminometer (Thermo Fisher Scientific Inc., Waltham, MA) and data processing of data was accomplished using the Ascent Software.
3 Results and discussion
LC-MS based metabolomics analysis
Metabolite extracts of I. hospitalis cells grown alone and in co-culture with N. equitans were analyzed using liquid chromatography-mass spectrometry (LC-MS). Three independent biological replicates were used for each type of cell culture. Differential analysis based on molecular feature intensity was used to compare sample groups. Figure 1a presents a cloud plot of reverse phase LC-MS metabolite data from I. hospitalis alone and in co-culture with N. equitans. Red circles indicate MS spectral features that are in greater abundance when I. hospitalis is grown alone, while green circles indicate features that are in greater abundance in the I. hospitalis-N. equitans coculture. The size of the circle indicates fold change between cultures and the shade of each color indicates p value, whereby larger, darker circles signify greater fold change and more significant p values. A number of differences between cultures were observed from these data. Greater than 3,000 molecular MS spectral features were detected between the 6 samples, with approximately 100 features being significantly distinct between groups (i.e. exhibiting fold changes greater than 1.5 and a p value less than 0.01). The vast majority of metabolite changes corresponded to decreases in metabolite abundance in the I. hospitalis-N. equitans co-cultures. Figure 1b displays the results from a principal component analysis (PCA) of molecular features identified from I. hospitalis and co-culture samples (in triplicate). This figure indicates that I. hospitalis-only cultures and I. hospitalis-N. equitans co-cultures clearly separate from each other along the first principal component (PC1) axis, with PC1 and PC2 accounting for *71 % of the variance between cultures. A Venn diagram of molecular features found exclusively in I. hospitalis or in co-culture samples, as well as the number of molecular features found in both sets of samples, is shown in Fig. 1c .
As a large number of molecular features were observed, data reduction was undertaken to tease out biologically interesting metabolites from the LC-MS metabolomics experiments. Two main data reduction strategies were conducted: First, a small in-house database of prominent and microbial-relevant compounds was created and annotated using retention times and masses (m/z ratios) of authentic standards. This database enabled positive identification of compounds based on both accurate mass and retention time characteristics. As establishing an exhaustive library of standards for all putative compounds is not practical, additional data reduction was conducted to further mine the data for biologically interesting compounds. Specifically, metabolites that are biologically relevant to the I. hospitalis-N. equitans system were highlighted by matching molecular masses within a 20 ppm mass error range to a list of expected compounds based on curated genome annotation via the Biocyc pathway tools software (Karp et al. 2010) . Fig. 1 Analysis of metabolites by Reverse Phase LC-MS, a Cloud plot of extracted metabolites from I. hospitalis grown alone top, and coculture of I. hospitalis and N. equitans bottom. Green circles denote a chromatographic peak whose mass spectral (MS) molecular feature is more abundant in the co-culture, and red circles denote a peak whose MS molecular feature is more abundant in I. hospitalis grown alone. The x-axis displays the retention/elution time of each molecular feature, while the y-axis indicates the m/z for each molecular feature. Only molecular features with a fold change greater than 1.5 and a p value less than 0.01 are shown. b A 2D PCA score plot indicating the separation of biological triplicates for I. hospitalis and the I. hospitalis-N equitans co-culture. The co-culture exhibits more variance in PC2 than the I. hospitalis samples; this likely arises from the variability that N. equitans contributes when grown with I. hospitalis. c Venn diagram indicating the number of unique and shared MS molecular features found in each sample (Color figure online) Untargeted metabolomics studies employing NMR and LC-MS 899
Metabolites identified via MS standards and pathway analysis of the LC-MS data are displayed in the first four columns of Table 1 . A fold change was calculated for each metabolite identified, where a positive number denotes a higher concentration when I. hospitalis is grown alone, and Figure S1 . Several sugars including maltotriose and stachyose had excellent m/z and retention time matches to standards, but could not be confirmed with MS/MS due to low abundance in the samples. The presence of such sugars is somewhat unexpected as metabolic pathways involving these molecules
have not yet been annotated in I. hospitalis or N. equitans (Huber et al. 2012 ).
NMR based metabolomics analysis
Analysis of metabolites by NMR is highly complementary to metabolite profiling by LC-MS. In addition to confirming putative metabolite identities from LC-MS, NMR yields quantitative information on metabolite concentrations, and is able to detect molecules that are not typically observed by LC-MS. Representative 1D 1 H NMR spectra obtained from metabolite extracts of I. hospitalis grown alone (Fig. 2a) , and in co-culture with N. equitans (Fig. 2b) show the rich spectral information of the samples. A total of 55 metabolites were identified from analysis of the 1D 1 H NMR spectra of I. hospitalis and I. hospitalis-N. equitans cultures, by matching NMR spectral patterns to reference metabolite spectra included in the 600 MHz Chenomx TM database of small molecules (Chenomx NMR Suite 7.0, 2010; Wishart 2008) . Figure 3a illustrates an example of NMR spectral pattern peak fitting used to match the experimental spectra to a specific metabolite pattern (in this case, glucose) included in the reference spectrum of the Chenomx database. A comparison of overall spectral intensities of the different samples shows, based on normalized amounts of cell material (see ''Materials and methods'' section), that the overall spectral intensity of the I. hospitalis-N-equitans co-culture samples is generally less than that of the I. hospitalis-only samples. Eighteen of the 20 common amino acids, energy-related molecules like ADP, and nucleotides identified by NMR were found to be higher in concentration in the I. hospitalis grown alone samples compared to I. hospitalis grown in co-culture with N. equitans. Columns four and five of Table 1 list metabolites identified by NMR. As with the LC-MS metabolite data, a positive fold change indicates higher concentration when I. hospitalis is grown alone, and a negative fold change indicates higher concentration when I. hospitalis is grown in co-culture with N. equitans. Figure 3b shows a close-up of overlaid NMR spectra of I. hospitalis (black) alone and co-culture (red); arrows highlight NMR signals that are higher in intensity in the I. hospitalis alone samples or more intense in the I. hospitalis-N-equitans co-culture samples.
Integration of LC-MS and NMR metabolic profiling
Metabolomics, one of the more recent ''omics'' additions to Systems Biology research, is increasingly used to enhance equitans co-culture sample than the ones observed for the I. hospitalis-only sample, following normalization of spectral intensities (as described in the text) (Color figure online) our global understanding of complex biological systems and the impact of environment and pressure on the biological responses and adaptation of organisms. At present, most metabolomics research employs either nuclear magnetic resonance (NMR) or mass spectrometry (MS), but rarely both. An important challenge in metabolomics is that a large fraction of the metabolites whose concentrations vary with alterations in biological conditions cannot be identified reliably using MS or NMR alone. NMR spectroscopy is very well suited for metabolomic analysis because a large number of small molecules can be assayed simultaneously in highly quantitative and reproducible manners. MS enables the analysis of a wide variety of compounds with excellent sensitivity. Using NMR and MS in concert enhances metabolic coverage and enables stronger identifications of key metabolic pathway components. Herein, integrating NMR and MS together has enabled to double the number of metabolites identified in I. hospitalis only and I. hospitalis-N. equitans co-cultures. The integrated NMR and MS metabolomics approach has been crucial for this study as growth of these two archaea is extremely difficult and sample availability is limited.
Overall, the LC-MS and NMR data analyses were highly complementary. The LC-MS-based approach was able to identify metabolites present at low concentrations, while metabolite profiling by NMR resulted in the confident identification and accurate concentrations of each NMR identified metabolite (*35 metabolites). Fifteen compounds were identified by both LC-MS and NMR, with comparable fold changes measured by both methods for almost all of these compounds. There were also cases where one method could not obtain a reliable fold difference between I. hospitalis alone and the I. hospitalis-N. equitans co-cultures, due to low metabolite signal intensity or overlapping spectral peaks, but the complementary method could. There were also cases (see L-Proline or L-Pyroglutamate for examples) in which the ability to confirm the presence of a metabolite by both methods was extremely helpful. In combination, nearly 70 metabolites were identified with the two techniques, clearly demonstrating the power of using both LC-MS and NMR for metabolomics profiling of challenging systems such as these two archaea.
Metabolic pathway analysis of LC-MS and NMR metabolomics data
The LC-MS and NMR metabolic profiles were analyzed in the context of annotated metabolic pathways for I. hospitalis and N. equitans and current understanding of cellular events regulating these species' interactions. Using the Pathway Tools program, protein abundance data from a recent proteomics study and the metabolites identified in this study, integrated changes were mapped onto known biochemical pathways of I. hospitalis and N. equitans (Karp and Paley 1996; Karp et al. 2005 Karp et al. , 2010 Karp et al. , 2002 Podar et al. 2008) . This approach produced a global, system-wide analysis of metabolic networks that seem to be guiding cellular interactions between these two organisms. The resulting metabolic network map showed overlap and complementarity of proteomic and metabolomic datasets in several key pathways including arginine biosynthesis, CTP/UTP biosynthesis, and nutrient recycling (Fig. 4) . Although other amino acid pathways were altered by the presence of N. equitans, a strong correlation between proteomic and metabolomics data was specifically observed for arginine and isoleucine biosynthesis, warranting further analysis of such metabolic networks. Interestingly, the biosynthetic pathway for arginine is upregulated in the co-culture. Separate pathways important for arginine biosynthesis converge at ornithine carboxylase, which produces citrulline from carbamoyl-phosphate and ornithine (Fig. 4a) . Citrulline is then converted to arginine in two steps involving arginosuccinate synthase and lyase enzymes. Proteomic analysis of the pathway showed increased abundance of carbamoyl phosphate synthase, ornithine carboxylase, and arginosuccinate lyase when N. equitans was present (Giannone et al. 2014) . Metabolite data was consistent with increased flux through the pathway, as the intermediates ornithine and citrulline decreased whereas the end product arginine increased in abundance in the presence of N. equitans. Further investigation of the proteomics data revealed that enzymes producing ornithine were down regulated when N. equitans is present. This provides a rationale as to why ornithine dropped nearly fourfold while arginine increased only twofold in the I. hospitalis-N. equitans co-cultures. This suggests that when N. equitans is present, the synthesis of arginine is largely accomplished through the consumption of available ornithine rather than by up-regulating enzymes needed to synthesize more ornithine. There are no other annotated pathways in I. hospitalis or N. equitans for which ornithine is a substrate, strongly suggesting that arginine biosynthesis leads to the decrease in ornithine. Together, the data imply that the interactions of I. hospitalis with N. equitans lead to induction of arginine synthesis at a low metabolic cost. This could be an important energy conservation mode, given the energetically depleted natural environment of these organisms and the resulting reduced strain on the energy balance of I. hospitalis (Thauer et al. 1977) . Lysine, another basic amino acid, is less costly to synthesize in terms of ATP required, and a larger increase in concentration was observed in the co-culture. The higher abundance of lysine in the I. hospitalis-N. equitans co-cultures is consistent with the amino acid needs of proteins in N. equitans which have enriched lysine while having lower arginine content (Podar et al. 2008 ).
Metabolite analysis indicated that the intracellular pool of amino acids was reduced in the presence of N. equitans. At the level of the proteome, the response is less clear (Giannone et al. 2014) . While up regulation of amino acid and protein synthetic pathways in the I. hospitalis host does not seem to be required to sustain N. equitans growth, specific anabolic pathways such as those for branched chain amino acids and their backup intracellular importer systems actually decreased in abundance in the co-culture systems (Giannone et al. 2014) . This suggests that sufficient amounts of amino acids exist in the cellular pool of I. hospitalis to meet the protein needs of N. equitans. Based on carefully conducted cell counts as reported in Giannone et al. 2014 (see their Fig. 1a) , the I. hospitalis-N equitans co-cultures used for the metabolomics studies contain approximately two N. equitans per I. hospitalis. At this ratio, only 2 % of the total cell mass is N. equitans. Using the reported protein concentration for prokaryotes of 100 mg/mL as established by NMR, the total protein content of N. equitans is estimated to be about half of what is lost from the I. hospitalis host (Moran et al. 2010) . Therefore, I. hospitalis would be expected to support growth of N. equitans through late-log phase without the need to synthesize de novo additional amino acids as a supply of amino acid precursors for N. equitans protein synthesis.
Based on the convergence of proteomic and metabolomics data, another pathway of particular interest was cytidine triphosphate (CTP) synthesis. This pathway is also energy intensive, involving the expenditure of three equivalents of adenosine triphosphate (ATP) to make one CTP (Fig. 4b) . Many of the proteins and metabolites in this pathway, as well as the upstream pathway for uridine monophosphate (UMP) biosynthesis, showed significantly lower abundance in the I. hospitalis-N. equitans co-culture samples. CTP is essential for the synthesis of the archaeal lipid, archaeol (Boucher et al. 2004) . Cytidine monophosphate was found by LC-MS to be at a higher concentration in I. hospitalis grown alone. From the observed depletion of CMP levels in the I. hospitalis-N. equitans co-cultures, we infer that CMP is converted to CTP to a greater extent in the I. hospitalis-N. equitans co-cultures, perhaps to be used for the biosynthesis of membrane archaeol lipids. During lipid synthesis, CTP becomes linked to the glycerol backbone of archaeol, forming CDP-archaeol (Boucher et al. 2004 ). The resulting lipid is then saturated by action of the enzyme geranyl-geranyl reductase, generating the active form of the lipid to be incorporated into cellular membranes.
The proteomics and metabolomics analyses together reveal a scenario revolving around N. equitans's use of metabolites generated by I. hospitalis as a source of energy rather than for biomass production. To further explore this hypothesis, ATP, ADP, and AMP levels were measured in both I. hospitalis only and I. hospitalis-N. equitans cocultures. Table 1 indicates that both LC-MS and NMR were able to identify AMP, and that NMR was also able to identify ADP. AMP was found to be in higher concentrations in the I. hospitalis only cultures, while ADP was found to be in a higher concentration in the co-culture. To quantify the ATP levels, a firefly luciferase assay was carried out. ATP was reproducibly measured to be at higher concentration when I. hospitalis is grown without N. equitans (Fig. 5) . The fact that ATP (high energy) and AMP (low energy) concentrations are in greater concentrations when I. hospitalis is grown alone, while the intermediate energy molecule ADP is higher in concentration in the I. hospitalis-N. equitans co-cultures suggests that there exists a significant energy demand for organism growth in the co-cultures. The trend of having more spent energy molecules (ADP) in the co-culture supports the notion that this additional energy demand placed upon I. hospitalis is necessary for growth of N. equitans and survival of its host I. hospitalis when the two species are grown together in co-cultures. To satisfy the increase in energy demand, the response of I. hospitalis to the presence of N. equitans seems to be to increase ATP production. The analysis was specifically presented in relative terms to normalize for possible degradation of nucleotide phosphate molecules due to the challenges of quenching samples grown at high temperature under hydrogen atmosphere.
Results from the luciferase assay suggested that the presence of N. equitans leads to increased ATP turnover. Some of this energy would likely be used to produce CTP, as suggested by the metabolic pathway analysis described above. This is supported by NMR metabolite profiling data which showed that the nucleotide bases (specifically cytidine and uridine) are higher in concentration in the I. hospitalis-N. equitans co-cultures, compared to the I. hospitalis only cultures. These results further support the notion that lipid production by I. hospitalis relies on available CTP levels, which originate from UMP biosynthesis as well as directly from cytidine metabolism.
Integration of results from proteomics and metabolomics experiments into a global scale analysis of metabolic pathways and networks of the combined cellular potential of these two organisms suggests that N. equitans exhibits parasitic function, not only consuming metabolites for energy production but also using I. hospitalis to build important structural and cellular components such as membrane lipids. Both LC-MS and NMR analyses have noted a large decrease in the overall intracellular metabolite pool when the two organisms are grown together, indicating that N. equitans stimulates the consumption of intracellular metabolites of I. hospitalis. Further analysis of the energy status of these cells demonstrates that the presence of N. equitans depletes high energy nucleotide (ATP) concentrations, and shifts the energy potential to a lower energy state as indicated by the increased concentrations of ADP in the I. hospitalis-N. equitans co-cultures.
3.5 Biological significance of the LC-MS and NMR metabolomics data
As noted above, both NMR and LC-MS metabolomics showed a decrease in abundance of most metabolites in the co-culture samples. Lower amino acid concentrations in the I. hospitalis-N equitans co-cultures suggest that those metabolites are utilized by N. equitans for protein biosynthesis, catabolized for energy production, or likely a combination of both. From this standpoint, it would suggest that N. equitans, as a user of I. hospitalis metabolic resources, may be acting more as a parasite rather than a mutualist with respect to metabolic needs of I. hospitalis. However, the question remains as to whether I. hospitalis could benefit from interactions with N. equitans, as many of the metabolic networks for these two organisms remain to be deciphered. For example, identification of maltotriose and stachyose as Standard deviation for each data point was less than 2 % significant I. hospitalis metabolites suggest that I. hospitalis may be capable of more complex carbohydrate metabolism than has been anticipated. The LC-MS data on carbohydrate intermediates suggest that glucose or other carbohydrate storage pathways may be present in I. hospitalis, and could serve to maintain proper cellular osmotic control as well as to satisfy other metabolic needs.
Conclusion
This study is the first metabolomics analysis of the I. hospitalis and N. equitans interaction. This work also emphasizes the benefits of using both LC-MS and NMR approaches, as more complete characterization of the metabolome of I. hospitalis and N. equitans was obtained. Through integration of our LC-MS and NMR metabolite profiles with previously published proteomics data, we have been able to map several key metabolic pathways that appear to modulate I. hospitalis-N equitans interspecies interactions. This study has highlighted key metabolic changes occurring when I. hospitalis is grown in co-culture with N. equitans. Although I. hospitalis is able to grow in the presence of N. equitans, our data suggests that there is a significant metabolic cost for the host organism. N. equitans seems to consume a large fraction of the small molecule pool of I. hospitalis, producing a sharp decrease in the energy status of the host. We cannot rule out that in their natural environment, the interactions between these two organisms with severely reduced genomes may confer an ecological advantage in the larger meta-microbial community, but the results of this study suggest that, at least under the laboratory conditions used here, N. equitans imposes a significant metabolic energy strain on I. hospitalis. The combination of NMR and MS for untargeted metabolomics analysis has proven to be very powerful and complementary. Often times, the two methods yielded similar metabolite identification with comparable fold change measured by both for the different I. hospitalis and I. hospitalis-N equitans samples. In some cases, metabolite identification was only possible using either LC-MS or NMR but not both, making the use of both analytical platforms a necessity. Furthermore, the additional sensitivity of LC-MS for low abundance molecules combined with the ability of NMR to obtain quantitative metabolite concentrations (as opposed to relative concentrations) demonstrate the highly advantageous application of both techniques to untargeted metabolite profiling of challenging microbial systems.
